Glucose-Guided Eating to Reduce Chronic Disease Risk: a Pilot Study
The Glucose-Guided Eating (GGE) pilot study, sponsored by Georgetown University, targets two high-risk populations: postmenopausal women with prediabetes and adolescent/young adult (AYA) cancer survivors. The intervention leverages a mobile app and continuous glucose monitoring (CGM) to promote healthier eating patterns, potentially reducing chronic disease risk. Given the rising prevalence of diabetes and obesity, this study addresses a significant market need. If successful, the GGE intervention could position Georgetown University as a leader in digital health solutions for chronic disease prevention, opening avenues for partnerships with tech companies and healthcare providers. The competitive landscape includes other digital health interventions, but GGE's unique focus on glucose-guided eating may differentiate it. Diligence should focus on regulatory pathways for the app and CGM integration, as well as potential reimbursement strategies.
Indication: Postmenopausal
Modality: behavioral intervention
Target: Glucose metabolism regulation through behavioral intervention and continuous glucose monitoring.
Sponsor: Georgetown University
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 18, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Glucose metabolism regulation through behavioral intervention and continuous glucose monitoring.
View original source fields
Condition raw: Postmenopausal, Prediabetes, Adolescent and Young Adult (AYA) Cancer Survivors
Condition normalized: Postmenopausal, Prediabetes, Adolescent and Young Adult (AYA) Cancer Survivors
Modality raw: behavioral intervention
Modality normalized: behavioral intervention
Target raw: Glucose metabolism regulation through behavioral intervention and continuous glucose monitoring.
Target normalized: Glucose metabolism regulation through behavioral intervention and continuous glucose monitoring.